
AdvaMed® Submits Comments on FY 2023 IPPS Proposed Rule
AdvaMed® submitted comments to CMS on the Fiscal Year 2023 Hospital Inpatient Prospective Payment System proposed rule.
Learn more about our Payment & Health Care Delivery Policy work.

AdvaMed® submitted comments to CMS on the Fiscal Year 2023 Hospital Inpatient Prospective Payment System proposed rule.

AdvaMed® submitted comments to the Center for Medicare and Medicaid Services (CMS) on its Radiation Oncology (RO) Model proposed rule proposing to indefinitely delay the start date of the RO…

AdvaMed® launched a Strategic Value Initiative to develop an approach and principles for assessing the value of medical technologies that can be adopted by health systems, payers, medtech companies, and…

AdvaMed® develops and advocates for sound payment policies that promote equitable patient access to diagnostic tests.

AdvaMed® develops strategies for improving Medicare coverage and payment systems and methodologies impacting patients, providers, and suppliers.

AdvaMed® submitted a letter regarding proposed local coverage determinations entitled “Skin Substitutes for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcer.”

AdvaMed® urged CDC to recognize the critical role evidence-based and FDA-approved/cleared devices can and should play in improving pain management and reducing opioid-related harms.

During two listening sessions, AdvaMed® provided responses to a set of questions posed by CMS on the parameters for a new TCET program, including the types of guidance provided by…

AdvaMed® submitted a response to a Department of Health and Human Services (HHS) Office of the National Coordinator for Health Information Technology (ONC) Request for Information (RFI) on electronic prior…

AdvaMed® submitted a response to a U.S. House of Representatives Healthy Futures Task Force, Subcommittee on Treatments (Subcommittee on Treatments) Request for Information (RFI) on information to help foster patient…